Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate |
2014-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102141081-B1 |
titleOfInvention |
Composition for skin cell anti-inflammation or skin whitening |
abstract |
The present invention relates to a composition for anti-inflammatory and skin whitening. Magnolin (Magnolin) according to the present invention can be used as a pharmaceutical composition, a cosmetic composition by inhibiting the production of NO by inhibiting the anti-inflammatory effect and melanin synthesis by inhibiting NO production of the skin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160020214-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102258838-B1 |
priorityDate |
2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |